Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Robert Hoyt, Peter Huang, and Jan Berger

Premium

Robert Hoyt has joined GenomeQuest's board of directors
Hoyt is currently Eximo's chief operating officer. Prior to that, he was the general manager of Endeca Technologies which sold to Oracle in 2011.


Cannabis Technologies has hired Peter Huang as its senior bioinformatician. In the role, he will work on enabling the company discover novel cannabis-based drug therapies to add to its growing pipeline.

Prior to joining the company, Huang was a senior bioinformatician at Vineland Research and Innovation Center, and before that, he was a bioinformatics scientist at US Genomics. He has extensive experience and knowledge in software development, database management, and computer system administration. He has an MS in botany and microbiology from Auburn University, and a BS in computer science from Simon Fraser University.


GNS Healthcare has tapped Jan Berger to serve on its board of directors.

Berger is currently president and CEO of Health Intelligence Partners, a consultancy that provides business strategies and solution. She has also served as CVS Caremark's chief clinical officer, among other positions.


The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.